Strategies to identify and develop antiviral peptides

Area of Science:

• Virology
• Biochemistry
• Nanotechnology

Background:

• Viral epidemics and pandemics present a significant global health challenge.
• Conventional small molecule antivirals face increasing issues with viral resistance.
• Peptides are emerging as a safer and more effective antiviral strategy with lower resistance potential.

Purpose of the Study:

• To explore the potential of antiviral peptides as a therapeutic option.
• To discuss methods for identifying and designing antiviral peptides.
• To highlight strategies for overcoming peptide limitations and enhancing their efficacy.

Main Methods:

• Screening of combinational peptide libraries using phage display.
• Utilizing peptide array libraries for antiviral identification.
• Rational design of peptides targeting specific viral mechanisms.
• Chemical modification to improve peptide bioavailability.
• Application of nanotechnology to enhance peptide stability and delivery.

Main Results:

• Peptides demonstrate inherent antiviral properties with reduced likelihood of inducing resistance.
• Phage display and peptide arrays are effective methods for discovering novel antiviral peptides.
• Chemical modifications and nanotechnology significantly improve peptide stability and therapeutic potential.
• Combined approaches enhance systemic circulation stability and antiviral activity.

Conclusions:

• Antiviral peptides represent a promising therapeutic avenue for combating viral infections.
• Overcoming limitations like poor bioavailability through chemical and nanotechnological strategies is crucial.
• Peptide-based therapies offer a viable alternative to conventional antivirals, addressing the challenge of drug resistance.